SMG
IART icon

Spectrum Management Group’s Integra LifeSciences IART Stock Holding History

Spectrum Management Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16
Closed -$1K – 323
2017
Q3 		$1K Buy
+16
New +$822 ﹤0.01% 321

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Spectrum Management Group's IART Position: Q4 2017 in Review

Spectrum Management Group sold out of Integra LifeSciences (IART) in Q4 2017, closing a stake of 16 shares — an estimated $1K sold.

Spectrum Management Group first reported a position in IART in Q3 2017 and held it in 1 quarter. The position peaked at $1K in Q3 2017. 221 funds tracked by Wall St. Rank hold IART as of Q4 2017.

  • Spectrum Management Group reported no remaining Integra LifeSciences position as of Q4 2017 after selling out during the quarter.
  • Spectrum Management Group sold 16 Integra LifeSciences shares in Q4 2017, an estimated $1K.
  • Spectrum Management Group first reported a position in Integra LifeSciences in Q3 2017 and held it in 1 quarter.
  • Spectrum Management Group's Integra LifeSciences position peaked at $1K in Q3 2017.
  • 221 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2017.

Based on Spectrum Management Group's 13F filing for Q4 2017, filed 7 Feb 2018.